ArticleJournal of comparative physiology. B, Biochemical, systemic, and environmental physiology2026
Chronic ammonia nitrogen induces integrated metabolic and immune reprogramming in the hepatopancreas of Macrobrachium rosenbergii.
Article in Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Total ammonia nitrogen (TAN) is a major cellular stressor in intensive Macrobrachium rosenbergii aquaculture; however, the molecular mechanisms underlying hepatopancreatic responses to chronic ammonia exposure remain insufficiently understood. In this study, juvenile prawns were exposed for seven days to TAN concentrations of 0 mg L⁻¹ (control), 2 mg L⁻¹, and 50 mg L⁻¹ under stable environmental conditions (27-28 °C, pH 7.5-8.0, dissolved oxygen 5-6 mg L⁻¹). No mortality was observed in the control group (100.0 ± 0.0%), while survival in the 2 mg L⁻¹ TAN group was slightly reduced (88.9 ± 3.2%) but not significantly different from the control (p > 0.05). In contrast, survival declined significantly to 75.0 ± 4.5% in the 50 mg L⁻¹ TAN group (p < 0.05). Moderate TAN exposure (2 mg L⁻¹) significantly altered hepatopancreatic gene expression, with 101 differentially expressed genes (47 up-regulated and 54 down-regulated) identified, primarily associated with extracellular matrix-receptor interactions, focal adhesion, lysosomal function, and phagosome-related processes, indicating epithelial remodeling and enhanced vesicular trafficking. High TAN exposure (50 mg L⁻¹) induced pronounced histopathological damage, including tubular disorganization, melanisation, and hemocyte infiltration, and was associated with 58 differentially expressed genes (26 up-regulated and 32 down-regulated) enriched in lysosomal activity, NOD-like receptor signalling, nitrogen metabolism, apoptosis, and antigen presentation pathways. Consistent with transcriptomic alterations, antioxidant enzyme activities (catalase, superoxide dismutase, and glutathione peroxidase) increased alongside elevated malondialdehyde levels, confirming oxidative stress. Collectively, these findings indicate that M. rosenbergii maintains a lysosome-associated adaptive response under moderate ammonia exposure, whereas higher TAN levels induce oxidative and inflammatory injury, defining critical thresholds of hepatopancreatic resilience.
Indexed as
Identifiers
42295373What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.